Facial paralysis after superselective intra-arterial chemotherapy via the middle meningeal artery in maxillary cancer

Effectiveness of CT assists for intraarterial chemotherapy: therapeutic outcome of chemoradiation for advanced head and neck cancer extending across the anatomical midline

“…However, to cover the posterior invasion, we had to inject cisplatin from the first portion of the IMA. From a previous report, direct infusion from the MMA does not always result in facial nerve palsy [17]. Therefore, we could not determine whether the nerve deficit was related to the dosage.…”

“…We injected cisplatin through the MMA in order to cover the entire tumor. Direct chemoinfusion through the MMA has been reported [17]; therefore, we anticipated this side effect. One patient died of sepsis and septic shock.…”

“…One case of neurological deficit occurred after cisplatin infusion from the first portion of the internal maxillary artery (IMA) because the patient suffered from advanced maxillary sinus carcinoma with posterior invasion. We thought that cisplatin flowed into the middle meningeal artery (MMA) and led to facial nerve damage [17]. However, to cover the posterior invasion, we had to inject cisplatin from the first portion of the IMA.…”